| Literature DB >> 36003618 |
Jing Zhang1,2, Luoxing Yang3, Jie Pei1,2, Yanzhang Tian1,2, Jiyang Liu3.
Abstract
Convenient and sensitive detection of tumors marked in serum samples is of great significance for the early diagnosis of cancers. Facile fabrication of reagentless electrochemical immunosensor with efficient sensing interface and high sensitivity is still a challenge. Herein, an electrochemical immunosensor was easily fabricated based on the easy fabrication of immunoassay interface with electron transfer wires, confined redox probes, and conveniently immobilized antibodies, which can achieve sensitive and reagentless determination of the tumor marker, carcinoembryonic antigen (CEA). Carboxyl multi-walled carbon nanotubes (MWCNTs) were firstly modified with an electrochemical redox probe, methylene blue (MB), which has redox potentials distinguished from those of redox molecules commonly existing in biological samples (for example, ascorbic acid and uric acid). After the as-prepared MB-modified MWCNT (MWCNT-MB) was coated on the supporting glassy carbon electrode (GCE), the MWCNT-MB/GCE exhibited improved active area and electron transfer property. Polydopamine (PDA) was then in situ synthesized through simple self-polymerization of dopamine, which acts as the bio-linker to covalently immobilize the anti-CEA antibody (Ab). The developed immunosensor could be applied for electrochemical detection of CEA based on the decrease in the redox signal of MB after specific binding of CEA and immobilized Ab. The fabricated immunosensor can achieve sensitive determination of CEA ranging from 10 pg/ml to 100 ng/ml with a limit of detection (LOD) of 0.6 pg/ml. Determination of CEA in human serum samples was also realized with high accuracy.Entities:
Keywords: carcinoembryonic antigen; electrochemical determination; immunosensor; label free; sensitive detection
Year: 2022 PMID: 36003618 PMCID: PMC9393226 DOI: 10.3389/fchem.2022.939736
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Schematic illustration for the fabrication of immunoanalysis interface and the following label-free electrochemical determination of CEA.
FIGURE 2(A) CV and DPV (inset) curves obtained on different electrodes in PBS electrolyte (0.1M, pH = 7.4). (B) CV curves obtained on PDA/MWCNT-MB/GCE during continuous cyclic voltammetry scanning.
FIGURE 3(A) CV curves of PDA/MWCNT-MB/GCE at different scan rate. The electrolyte solution is 0.1 M PBS (pH = 7.4). (B) The linear regression curve between the oxidation peak current or reduction peak current and scan rate.
FIGURE 4SEM images of MWCNT-MB (left) and PDA/MWCNT (right) modified glassy carbon sheet.
FIGURE 5(A) CV obtained on different electrodes. (B) Nyquist plots obtained in KCl (0.1 M) containing Fe(CN)6 3/4− (2.5 mM). Inset is the magnified Nyquist plots, respectively. (C) The peak current obtained after CEA binding on different immunosensors fabricated using different reaction time between PDA and Ab. (D) The peak current obtained after CEA binding using different incubation time between CEA and Ab. The concentration of Ab for the fabrication of the immunosensor is 100 μg/ml. The used concentration of CEA is 1 ng/ml.
FIGURE 6(A) Electrochemical response of the immunosensor in presence of different concentrations of CEA. Inset is the calibration curve for the determination of CEA. (B) Relative ratio of peak current before (I 0) and after (I) incubation with CEA, CEA + PSA, CEA + CA125, CEA + S-100 or the mixture containing CEA, PSA, CA125, S-100. The concentration of CEA and other proteins are 0.1 ng/ml and 10 ng/ml, respectively. (C) The peak current obtained using five different electrodes. (D) The peak current obtained using electrodes stored for different time.